Physician profile
Charles Kim
NPI 1104242924
$20,611.92
in general payments reported to CMS, 2019-2025
11 companies · $9,870 in 2025
The $9,870 reported for 2025 was more than what 91% of Ophthalmic Plastic and Reconstructive Surgery providers received nationally (typical 2025 total: $299).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $26.92 · 2020: $92.34 · 2021: $110 · 2022: $178 · 2023: $4,427 · 2024: $5,907 · 2025: $9,870.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $14K · Honoraria: $4,200 · Food and Beverage: $917 · Consulting Fee: $850.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $14,237.50 |
| Honoraria | $4,200.00 |
| Food and Beverage | $916.77 |
| Consulting Fee | $850.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $15,726.09 | 2024-2025 | Tepezza |
| Horizon Therapeutics Plc | $4,593.65 | 2021-2023 | Tepezza |
| Allergan, INC. | $118.36 | 2020-2021 | |
| Optos, INC. | $49.02 | 2019-2022 | |
| Merz North America, INC. | $33.09 | 2025 | |
| Oyster Point Pharma, INC. | $25.40 | 2022 | |
| Carl Zeiss Meditec Ag | $19.40 | 2020 | |
| Alcon Vision LLC | $17.93 | 2025 | Eysuvis |
| Carl Zeiss Meditec, INC. | $17.24 | 2020 | |
| Nevro Corp. | $11.74 | 2022 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Charles Kim listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.